SHOGUN Tirzepatide 10mg
Tirzepatide is a injectable prescription medicine used to treat type 2 diabetes, manage chronic weight loss, and treat moderate-to-severe obstructive sleep apnea in adults with obesity. It works as a dual GIP and GLP-1 receptor agonist.
Uses and How It Works
- Type 2 Diabetes: Lowers high blood sugar by helping the pancreas release the correct amount of insulin.
- Weight Management: Decreases appetite and slows stomach emptying to create a feeling of fullness.
- Mechanism: Activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.
Dosage and Administration
- Schedule: Given as a subcutaneous injection (under the skin) once a week.
- Sites: Injected into the stomach area, thigh, or upper arm, rotating the site with each dose.
- Titration: Typically starts at 2.5 mg once weekly for four weeks, then increases in 2.5 mg steps as tolerated up to a maximum maintenance dose of 15 mg weekly.
Side Effects and Risks
- Common Effects: Nausea, vomiting, diarrhea, constipation, stomach pain, and reduced appetite.
- Serious Risks: Potential for pancreatitis, gallbladder problems, kidney injury, and severe allergic reactions.
